Marex Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Buy
+6,173
New +$301K ﹤0.01% 821
2025
Q4
Sell
-4,919
Closed -$203K 1028
2025
Q3
$203K Buy
+4,919
New +$198K ﹤0.01% 713
2025
Q2
Sell
-6,766
Closed -$250K 747
2025
Q1
$250K Buy
6,766
+236
+4% +$8.41K ﹤0.01% 512
2024
Q4
$217K Buy
+6,530
New +$212K ﹤0.01% 526
2024
Q3
Sell
-13,947
Closed -$313K 679
2024
Q2
$313K Buy
13,947
+3,182
+30% +$70.6K 0.01% 402
2024
Q1
$255K Buy
10,765
+77
+0.7% +$1.71K 0.01% 349
2023
Q4
$256K Buy
+10,688
New +$232K 0.01% 415

Other funds holding EXEL

Marex Group's EXEL Position: Q2 2026 in Review

Marex Group opened a new position in Exelixis (EXEL) in Q2 2026: 6,173 shares worth $336K. The stake represents ﹤0.01% of the portfolio and ranks #821 among its holdings. This is a return to the name: Marex Group previously reported a position in EXEL as recently as Q3 2025.

Marex Group first reported a position in EXEL in Q4 2023 and has held it in 7 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Marex Group held 6,173 shares of Exelixis worth $336K as of Q2 2026.
  • Exelixis was a new Marex Group position in Q2 2026.
  • Exelixis made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #821 holding.
  • Marex Group first reported a position in Exelixis in Q4 2023 and has held it in 7 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.